Literature DB >> 1898445

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

J W Pettegrew1, M S Keshavan, K Panchalingam, S Strychor, D B Kaplan, M G Tretta, M Allen.   

Abstract

In this pilot study, membrane phospholipid and high-energy phosphate metabolism were studied in the dorsal prefrontal cortex of 11 drug-naive, first-episode schizophrenic patients and compared with those of 10 healthy control volunteers comparable in age, education, and parental education. The schizophrenic patients had significantly reduced levels of phosphomonoesters and inorganic orthophosphate and significantly increased levels of phosphodiesters and adenosine triphosphate compared with the controls. The levels of phosphocreatine and adenosine diphosphate did not differ in the two subject groups. The adenosine triphosphate and inorganic orthophosphate findings suggest functional hypoactivity of the dorsal prefrontal cortex. The phosphomonoester and phosphodiester findings are compatible with either premature aging or an exaggeration of normal programmed regressive events occurring in the neural systems sampled.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1898445     DOI: 10.1001/archpsyc.1991.01810300075011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  52 in total

1.  Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia.

Authors:  Frank A Middleton; Karoly Mirnics; Joseph N Pierri; David A Lewis; Pat Levitt
Journal:  J Neurosci       Date:  2002-04-01       Impact factor: 6.167

Review 2.  Sources of heterogeneity in schizophrenia: the role of neuropsychological functioning.

Authors:  B E Seaton; G Goldstein; D N Allen
Journal:  Neuropsychol Rev       Date:  2001-03       Impact factor: 7.444

Review 3.  Neuropsychiatric rehabilitation for persistent mental illness.

Authors:  J Jaeger; E Douglas
Journal:  Psychiatr Q       Date:  1992

4.  Association studies of cytosolic phospholipase A2 polymorphisms and schizophrenia among two independent family-based samples.

Authors:  K V Chowdari; B Brandstaetter; P Semwal; T Bhatia; S Deshpande; R Reddy; J Wood; C R Weinberg; B K Thelma; V L Nimgaonkar
Journal:  Psychiatr Genet       Date:  2001-12       Impact factor: 2.458

5.  Hippocampal Pruning as a New Theory of Schizophrenia Etiopathogenesis.

Authors:  Enrico Cocchi; Antonio Drago; Alessandro Serretti
Journal:  Mol Neurobiol       Date:  2015-04-24       Impact factor: 5.590

6.  What is schizophrenia: A neurodevelopmental or neurodegenerative disorder or a combination of both? A critical analysis.

Authors:  Swapnil Gupta; Parmanand Kulhara
Journal:  Indian J Psychiatry       Date:  2010-01       Impact factor: 1.759

Review 7.  Defects in Bioenergetic Coupling in Schizophrenia.

Authors:  Courtney R Sullivan; Sinead M O'Donovan; Robert E McCullumsmith; Amy Ramsey
Journal:  Biol Psychiatry       Date:  2017-10-24       Impact factor: 13.382

8.  Deficit in prepulse inhibition in mice caused by dietary n-3 fatty acid deficiency.

Authors:  Irina Fedorova; Anita R Alvheim; Nahed Hussein; Norman Salem
Journal:  Behav Neurosci       Date:  2009-12       Impact factor: 1.912

9.  Altered fatty acid concentrations in prefrontal cortex of schizophrenic patients.

Authors:  Ameer Y Taha; Yewon Cheon; Kaizong Ma; Stanley I Rapoport; Jagadeesh S Rao
Journal:  J Psychiatr Res       Date:  2013-02-18       Impact factor: 4.791

10.  Cortical surface characteristics among offspring of schizophrenia subjects.

Authors:  Konasale M Prasad; Dhruman Goradia; Shaun Eack; Malolan Rajagopalan; Jeffrey Nutche; Tara Magge; Rajaprabhakaran Rajarethinam; Matcheri S Keshavan
Journal:  Schizophr Res       Date:  2009-12-04       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.